Alzamend Neuro (ALZN) Stock: Buy, Sell, or Hold?
ALZN - Alzamend Neuro, Inc. Common Stock
$1.30
-0.03 (-2.26%)
▼
5d:
-3.7%
30d:
-32.99%
90d:
-3.7%
HOLD
LOW Confidence
Analysis Updated: Oct 20, 2026 12:00 AM ET
Earnings: Dec 08, 2026
Get Alerted When ALZN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ALZN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ALZN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ALZN is currently trading at $1.30, which is considered oversold relative to its 30-day fair value range of $1.33 to $1.83.
Technical Outlook: Technically, ALZN is in a strong uptrend. Immediate support is located at $1.22, while resistance sits at $1.43.
Market Sentiment: ALZN scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $26.00 (+1900.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALZN is in a strong uptrend. Immediate support is located at $1.22, while resistance sits at $1.43.
Market Sentiment: ALZN scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $26.00 (+1900.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.33 -
$1.83
Company Quality Score
69/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (91/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1900.0% below Wall St target ($26.00)
- CAUTION: Bottoming setup, but lagging the sector by 23% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.33 -
$1.83
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.22
Resistance Level
$1.43
Current Trend
Strong Uptrend
Technical data as of
Oct 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.50
Wall Street Target
$26.00
(+1900.0%)
Share & Embed Analysis
Last updated: October 20, 2026 7:54 PM ET
Data refreshes hourly during market hours. Next update: 8:54 PM
Data refreshes hourly during market hours. Next update: 8:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALZN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1153 | 58 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 53 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 55 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 57 HOLD |
|
ORKA
Oruka Therapeutics, Inc. |
STRONG BUY
13 analysts |
$155 | 71 BUY |
